Literature DB >> 12667204

Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.

Robert Sealy1, Sherri Surman, Julia L Hurwitz, Christopher Coleclough.   

Abstract

Our previous studies of C57BL/6 mice intranasally infected with influenza virus (A/PR8) revealed a spike of virus-specific immunoglobulin A (IgA)-secreting antibody-forming cells (AFC) in the mediastinal lymph node (MLN) 7 days post-infection. Here we show that these AFC are directed only against viral glycoprotein, and not nucleocapsid antigens. The early IgA spike associates with a decline in glycoprotein-specific AFC during week 2 post-infection. In contrast to the glycoprotein-specific AFC, nucleocapsid-specific, IgA-secreting AFC develop gradually in the MLN and persist for more than 3 weeks post-infection. As peripheral lymph node reactions wane, the nucleocapsid-specific AFC appear as long-sustained populations in the bone marrow. Microanatomical examination of the respiratory tract in infected mice shows foci of infection established in the lung 2 days post-infection, from which virus spreads to infect the entire lining of the trachea by day 3. At this time, viral haemagglutinin can be seen within the MLN, probably on projections from infected dendritic cells. This feature disappears within a day, though viral antigen expression continues to spread throughout the respiratory tract. Total IgA- and IgG-secreting AFC appear histologically in large numbers during the first week post-infection, significantly preceding the appearance of germinal centres (revealed by peanut agglutinin staining in week 2). To explain these results, we suggest that the initial immunogenic encounter of B cells with viral antigens occurs about 3 days post-infection in the MLN, with antigens transported by dendritic cells from airway mucosa, the only site of viral replication. Viral glycoproteins expressed as integral membrane components on the surface of infected dendritic cells [probably in the absence of cognate T helper (Th) cells] promote members of expanding relevant B-cell clones to undergo an IgA switch and terminal local plasmacytoid differentiation. Anti-glycoprotein specificities are thus selectively depleted from progeny of activated B-cell clones which are channelled to participate in germinal centre formation (perhaps by cognate T helper cells when they become sufficiently frequent). One product of the germinal centre reaction is the long-sustained, bone marrow-resident population, which is accordingly rich in anti-nucleoprotein, but not anti-glycoprotein specificities. Of note, we find that AFC responses toward influenza virus and Sendai virus differ, even though viral replication is limited to the airway mucosa in each case. The response towards Sendai virus exhibits neither the early appearance of anti-glycoprotein AFC expressing IgA in draining lymph nodes, nor the subsequent relative deficit of this specificity from bone marrow AFC populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667204      PMCID: PMC1782924          DOI: 10.1046/j.1365-2567.2003.01615.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells.

Authors:  A Langenkamp; M Messi; A Lanzavecchia; F Sallusto
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

2.  Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens.

Authors:  Y J Liu; J Zhang; P J Lane; E Y Chan; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

3.  Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.

Authors:  B E Johansson; D J Bucher; E D Kilbourne
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments.

Authors:  M Sangster; L Hyland; R Sealy; C Coleclough
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

5.  Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.

Authors:  B E Johansson; T M Moran; C A Bona; S W Popple; E D Kilbourne
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

6.  Respiratory virus infection of mice provokes a permanent humoral immune response.

Authors:  L Hyland; M Sangster; R Sealy; C Coleclough
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype.

Authors:  S R Sarawar; M Sangster; R L Coffman; P C Doherty
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

8.  Virally induced modulation of murine IgG antibody subclasses.

Authors:  J P Coutelier; J T van der Logt; F W Heessen; A Vink; J van Snick
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

9.  EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICE. I. THE PERIOD OF TRANSMISSIBILITY.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations.

Authors:  J Jacob; R Kassir; G Kelsoe
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  25 in total

1.  Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Authors:  Yuan Fang; David Banner; Alyson A Kelvin; Stephen S H Huang; Christopher J Paige; Steven A Corfe; Kevin P Kane; R Chris Bleackley; Thomas Rowe; Alberto J Leon; David J Kelvin
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 2.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

Review 3.  Protective B cell responses to flu--no fluke!

Authors:  Elizabeth E Waffarn; Nicole Baumgarth
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

4.  Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.

Authors:  Katherine Kedzierska; Vanessa Venturi; Kenneth Field; Miles P Davenport; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

5.  Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; William J Quinn; Michele Metzgar; Katie L Williams; Andrew J Caton; Eric Meffre; Richard J Bram; Loren D Erickson; David Allman; Michael P Cancro; Jan Erikson
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

6.  Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.

Authors:  R Sealy; B G Jones; S L Surman; J L Hurwitz
Journal:  Vaccine       Date:  2010-08-01       Impact factor: 3.641

7.  Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.

Authors:  Attapon Kamlangdee; Brock Kingstad-Bakke; Jorge E Osorio
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

8.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

9.  B-cell fate decisions following influenza virus infection.

Authors:  Kristina Rothaeusler; Nicole Baumgarth
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

10.  A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

Authors:  Damian M Carragher; Denise A Kaminski; Amy Moquin; Louise Hartson; Troy D Randall
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.